Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Introduced by Novo Nordisk in 2026, oral semaglutide became the first oral GLP-1 medication approved explicitly for weight loss
Tirzepatide is another groundbreaking medication, designed to mimic both GLP-1 and another hormone called GIP (glucose-dependent insulinotropic polypeptide)
Dr Reddy's is planning a rollout of semaglutide across 87 countries next year, with day 1 launches in India and Brazil as patents expire
Exceptions and limitations : Over-the-counter drugs are usually not covered unless prescribed for a specific medical condition
Regular check-ins with your healthcare provider ensure that the treatment remains effective and tailored to your ongoing needs
US$ 24.49
US$ 20.25
US$ 24.11
US$ 21.20
US$ 21.47
